Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 1, 2006, Pages 108-116

  Fang, L Christine ^a   Komaki, Ritsuko ^a   Allen, Pamela ^a   Guerrero, Thomas ^a   Mohan, Radhe ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Medically inoperable; Non small cell lung cancer; Stage I; Three dimensional conformal radiotherapy; Two dimensional radiotherapy

Indexed keywords

DISEASES; PATIENT MONITORING; PLANNING; STATISTICAL METHODS; TUMORS;

MEDICALLY INOPERABLE; NON-SMALL-CELL LUNG CANCER; STAGE I; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY; TWO-DIMENSIONAL RADIOTHERAPY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TUMOR VOLUME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33746855492     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.04.015     Document Type: Article

References (54)

1. Morrison R., and Cleland W.P. The treatment of carcinoma of the bronchus. A clinical trial to compare surgery and supervoltage radiotherapy. Lancet 1 (1963) 683-684
2. Hayakawa K., Mitsuhashi N., Saito Y., et al. Limited field irradiation for medically inoperable patients with peripheral Stage I nonsmall cell lung cancer. Lung Cancer 26 (1999) 137-142
3. Dosoretz D.E., Galmarini D., Rubenstein J.H., et al. Local control in medically inoperable lung cancer. An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 27 (1993) 507-516
4. Sibley G.S., Jamieson T.A., Marks L.B., Anscher M.S., and Prosnitz L.R. Radiotherapy alone for medically inoperable Stage I non-small-cell lung cancer. The Duke experience. Int J Radiat Oncol Biol Phys 40 (1998) 149-154
5. Krol A.D., Aussems P., Noordijk E.M., Hermans J., and Leer J.W. Local irradiation alone for peripheral stage I lung cancer. Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 34 (1996) 297-302
6. Slotman B.J., Antonisse I.E., and Njo K.H. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 41 (1996) 41-44
7. Kaskowitz L., Graham M.V., Emami B., Halverson K.J., and Rush C. Radiation therapy alone for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 27 (1993) 517-523
8. Bradley J.D., Wahab S., Lockett M.A., Perez C.A., and Purdy J.A. Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 56 (2003) 342-347
9. Cheung P.C., MacKillop W.J., Dixon P., Brundage M.D., Youssef Y.M., and Zhou S. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 703-710
10. Cheung P.C., Yeung L.T., Basrur V., Ung Y.C., Balogh J., and Danjoux C.E. Accelerated hypofractionation for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1014-1023
11. Dosoretz D.E., Katin M.J., Blitzer P.H., et al. Radiation therapy in the management of medically inoperable carcinoma of the lung. Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 24 (1992) 3-9
12. Firat S., Bousamra M., Gore E., and Byhardt R.W. Comorbidity and KPS are independent prognostic factors in Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 1047-1057
13. Gauden S., Ramsay J., and Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108 (1995) 1278-1282
14. Graham P.H., Gebski V.J., and Langlands A.O. Radical radiotherapy for early non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 31 (1995) 261-266
15. Jeremic B., Shibamoto Y., Acimovic L., and Milisavljevic S. Hyperfractionated radiotherapy alone for clinical Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 38 (1997) 521-525
16. Kupelian P.A., Komaki R., and Allen P. Prognostic factors in the treatment of node-negative non-small-cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36 (1996) 607-613
17. Lagerwaard F.J., Senan S., van Meerbeeck J.P., et al. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for Stage I non-small-cell lung cancer?. Radiother Oncol 63 (2002) 151-157
18. Slotman B.J., Njo K.H., and Karim A.B. Curative radiotherapy for technically operable Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 29 (1994) 33-37
19. Naruke T., Goya T., Tsuchiya R., and Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 (1988) 440-447
20. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 111 (1997) 1710-1717
21. Vijayakumar S., Myrianthopoulos L.C., Rosenberg I., Halpern H.J., Low N., and Chen G.T. Optimization of radical radiotherapy with beam's eye view techniques for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 21 (1991) 779-788
22. Blackstock A.W., Hendon II J.E., Paskett E.D., et al. Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma. report from the Cancer and Leukemia Group B. J Natl Cancer Inst 94 (2002) 284-290
23. Pater J.L., and Loeb M. Nonanatomic prognostic factors in carcinoma of the lung. A multivariate analysis. Cancer 50 (1982) 326-331
24. Stanley K.E. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65 (1980) 25-32
25. Martel M.K., Hayman J.A., and Ball D. Incidental dose to clinically negative nodes from conformal treatment fields for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 45 Suppl (1999) 244
26. Morita K., Fuwa N., Suzuki Y., et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I. A retrospective analysis of 149 patients. Radiother Oncol 42 (1997) 31-36
27. Sandler H.M., Curran Jr. W.J., and Turrisi III A.T. The influence of tumor size and pretreatment staging on outcome following radiation therapy alone for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 19 (1990) 9-13
28. Fletcher G.H. Clinical dose response curves of human malignant epithelial tumours. Br J Radiol 46 (1973) 151
29. Arita T., Kuramitsu T., Kavamura M., et al. Bronchogenic carcinoma. Incidence of metastases to normal sized lymph nodes. Thorax 50 (1995) 1267-1269
30. Tahara R.W., Lackner R.P., and Graver L.M. Is there a role for routine mediastinoscopy in patients with peripheral T1 lung cancers?. Am J Surg 180 (2000) 488-492
31. Koike T., Terashima M., Takizawa T., et al. Clinical analysis of small-sized peripheral lung cancer. J Thorac Cardiovasc Surg 115 (1998) 1015-1020
32. Ginsberg R.J., Rubinstein L.V., and Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 60 (1995) 615-623
33. Sahn S.A., Nett L.M., and Petty T.M. Ten year follow-up of a comprehensive rehabilitation program for severe COPD. Chest 77 Suppl (1980) 311-314
34. Cooper J.D., Pearson G., Todd T.R., et al. Radiotherapy alone for patients with operable carcinoma of the lung. Chest 87 (1985) 289-292
35. Zhang H.X., Yin W.B., Zhang L.J., et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14 (1989) 89-94
36. Perez C.A., Pajak T.F., Rubin P., et al., Report by the Radiation Therapy Oncology Group. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 59 (1987) 1874-1881
37. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311. A Phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
38. Hanley J., Debois M.M., Mah D., et al. Deep inspiration breath-hold technique for lung tumors. The potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys 45 (1999) 603-611
39. Kim D.J., Murray B.R., Halperin R., and Roa W.H. Held-breath self-gating technique for radiotherapy of non-small-cell lung cancer. A feasibility study. Int J Radiat Oncol Biol Phys 49 (2001) 43-49
40. Mah D., Hanley J., Rosenzweig K.E., et al. Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. Int J Radiat Oncol Biol Phys 48 (2000) 1175-1185
41. Wong J.W., Sharpe M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44 (1999) 911-919
42. Rosenzweig K.E., Hanley J., Mah D., et al. The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 81-87
43. Mageras G.S., and Yorke E. Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatment. Semin Radiat Oncol 14 (2004) 65-75
44. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for Stage I non-small-cell lung carcinoma. Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
45. Bush D.A., Slater J.D., Shin B.B., et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126 (2004) 1198-1203
46. Bonnet R.B., Bush D., Cheek G.A., et al. Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer. Chest 120 (2001) 1803-1810
47. Santos R., Colonias A., Parda D., et al. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with stage I non-small-cell lung cancer. Surgery 134 (2003) 691-697
48. Sasaki M., Ichiya Y., Kuwabasa Y., et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer. A comparative study with X-ray computed tomography. Eur J Nucl Med 23 (1996) 741-747
49. Steinert H.C., Hauser M., Allemann F., et al. Non-small cell lung cancer. Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 202 (1997) 441-446
50. Valk P.E., Pounds T.R., Hopkins D.M., et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 60 (1995) 1573-1582
51. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
52. Hicks R.J., Kalff V., MacManus M.P., et al. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small-cell lung cancer. J Nucl Med 42 (2001) 1596-1604
53. Gohagan J.K., Prorok P.C., Hayes R.B., et al. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute. History, organization, and status. Control Clin Trials 21 Suppl. 6 (2000) 251S-272S
54. Swensen S.J., Jett J.R., Hartman T.E., et al. CT screening for lung cancer. Five-year prospective experience. Radiology 235 (2005) 259-265